Table 2 Various p -values for the pharmacological data set at the nominal level α =5 %
From: Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints
|  | θ=0.6 |  | θ=0.8 | ||||
|---|---|---|---|---|---|---|---|
Test method | T W | T R | T L | Â | T W | T R | T L |
AM | 0.173 | 0.162 | 0.164 | Â | 0.234 | 0.229 | 0.230 |
SAM | 0.494 | 0.494 | 0.140 | Â | 0.497 | 0.497 | 0.162 |
EUM | 0.185 | 0.181 | 0.192 | Â | 0.233 | 0.202 | 0.210 |
AUM | 0.166 | 0.165 | 0.186 | Â | 0.232 | 0.230 | 0.249 |
BTM | 0.504 | 0.502 | 0.519 | Â | 0.516 | 0.514 | 0.530 |